Can Drug Companies Bribe the FDA?

| June 23, 2019

article image
With drugs such as Lipitor achieving lifetime sales well over $100 billion, the motivation to use any means available to ensure drug approval is clear. Bribery of FDA officials has occurred in the past, but is unlikely to occur again for the reasons described below. The overall objective of the drug approval process is to demonstrate the safety and efficacy of a drug. This process takes many years, and involves a large number of people working for many different institutions.

Spotlight

CELOGEN PHARMA PVT LTD

We would like to introduce ourselves as a new leading pharmaceutical formulations exporter/manufacturer based in India. Currently operating in some 15 countries globally we cover parts of West Africa, East Africa, South Asia, South East Asia, the Middle East & Europe. Apart from promoting our branded products in the retail sector, we also participate in a number of global tenders which are backed by the Unicef, World Bank, WHO & the local governments in a number of countries. The team comprises of a group of first generation marketing expats, who are backed up by some of the best technocrats in the field today. We have four Manufacturing Bases in Southern parts of India, manufacturing a variety of products. Our specialty however lies in the fabrication of 1st,2nd,3rd & 4th Generation Anti-biotics, ONCOLOGY Injectables, nutritional products such as Multi-Vitamins & essential oils in soft gel forms, anti-malarial & anti-TB drugs. We have also recently launched a number of higher end ant

OTHER ARTICLES

Pharmacist eCare Plan - the newest disrupter in health data exchange?

Article | February 25, 2020

Every member of the health care team shares a common goal of optimizing patient outcomes. Yet each specialty and position of the healthcare team has a unique workflow facilitated by various tools, from an operative report to a progress note. In this regard the pharmacist plays a pivotal function in medication management and requires documentation specific to that role. The Pharmacist eCare Plan (PeCP) allows for an interoperable note to be used in the pharmacy to assist in the exchange of patient information, including active medication list, laboratory results, and payer information. To allow for this, a new type of clinical document architecture for the PeCP was created and standardized for use across pharmacies.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 6, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 17, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | March 4, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Spotlight

CELOGEN PHARMA PVT LTD

We would like to introduce ourselves as a new leading pharmaceutical formulations exporter/manufacturer based in India. Currently operating in some 15 countries globally we cover parts of West Africa, East Africa, South Asia, South East Asia, the Middle East & Europe. Apart from promoting our branded products in the retail sector, we also participate in a number of global tenders which are backed by the Unicef, World Bank, WHO & the local governments in a number of countries. The team comprises of a group of first generation marketing expats, who are backed up by some of the best technocrats in the field today. We have four Manufacturing Bases in Southern parts of India, manufacturing a variety of products. Our specialty however lies in the fabrication of 1st,2nd,3rd & 4th Generation Anti-biotics, ONCOLOGY Injectables, nutritional products such as Multi-Vitamins & essential oils in soft gel forms, anti-malarial & anti-TB drugs. We have also recently launched a number of higher end ant

Events